Delivery Order SPE2DB24D2003-SPE2DB24FXFM6
Award Date
7/11/24
Potential Completion Date
7/12/24
Potential Value
$4.4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of Advair HFA 230-21 MCG inhalers to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor, through its Corporate Office division. The contract has a total ceiling value of $4,877.12 and is a firm fixed-price delivery order, with an ultimate completion date of June 4, 2024. The contract was awarded on June 3, 2024, and there...
This federal contract award is for the delivery of Advair HFA 230-21 MCG inhalers to the Defense Logistics Agency (DLA). The $9,604.00 fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The award has a completion date of May 7, 2024. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide...
This federal contract award is for the delivery of Advair HFA 230-21 MCG inhalers to the Defense Logistics Agency (DLA). The $8,438.27 Firm Fixed Price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on August 12, 2024 with a performance period through August 13, 2024. The award is not associated with any set-aside requirements. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This federal contract award is for the delivery of Advair HFA 230-21 MCG inhalers to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The $2,923.01 firm-fixed-price contract does not have a set-aside designation and was awarded on May 23, 2024, with a completion date of May 24, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Advair HFA 115-21 MCG inhalers. The $12,577.37 contract has a period of performance through March 22, 2024. Amerisourcebergen Drug Corp is the prime contractor and no set-aside designation was used. This award is associated with a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 that...
The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract worth $3,549.84 to Amerisourcebergen Drug Corp, a leading pharmaceutical distribution company, for the provision of Advair HFA 230-21 MCG Inhaler 12GM. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen Drug Corp holds with DLA to supply a comprehensive range of pharmaceutical products and medical supplies to military...
This federal contract award is for the delivery of Advair HFA 115-21 MCG Inhaler 12GM to the Defense Logistics Agency (DLA) Troop Support Medical. The $2,408.29 firm fixed price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distributor. The award has an ultimate completion date of April 10, 2024. Amerisourcebergen Drug Corp has an existing indefinite delivery contract (IDC) with DLA, valued at up to...
This federal contract award is a delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Advair HFA 115-21 MCG Inhaler 12GM to the Defense Logistics Agency. The $3,657.90 firm fixed-price contract has a performance period through June 9, 2025 and is not set aside. AmerisourceBergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical to provide a broad range of pharmaceutical...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Advair HFA 45-21 mcg inhalers. The $2,706.60 contract has an ultimate completion date of April 1, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp by DLA, with a potential value of $999,999,999.00 and a performance period through...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,346.56 firm fixed-price Delivery Order covers the supply of Advair HFA 115-21 MCG Inhaler 12GM to support military healthcare programs. The contract has an ultimate completion date of May 23, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...